Skip to content Skip to footer


KeyZell is a unique investment opportunity

The search for a cure for cancer is a pressing need of our society, for which large investments are required, which has made this fight one of the most lucrative businesses on the planet, surpassing even the technology sector.

According to the latest study published by the IQVIA Institute, “Global Oncology Trends 20211”, the global market in treatments for this disease is estimated to reach 269 billion dollars by 2025.

This market is led by the US, which has a 42% share, followed by the top five European markets: Germany, France, Great Britain, Italy, and Spain. Today, KeyZell has in clinical phase a drug for the treatment of lung cancer, LZ-167 and another drug LK-183, for the prevention and avoidance of metastasis.


Want to know more?

The Investor's area